JLL represents landlord in lease to AnaBios which brings the property to 50 percent leased
SAN DIEGO, CALIF., March 28, 2024 – Confirming that Downtown San Diego is a growing life science cluster, Phase 3 Real Estate Partners, Inc. has proudly announced its newest lease with AnaBios within the highly coveted GENESIS-San Diego. This cutting-edge, eight-story, 200,000-square-foot Class A life science building, established itself as a premiere facility for some of the most forward-thinking life science companies in San Diego.
The signing of AnaBios to a new 20,000-square-foot lease GENESIS-San Diego brings the property to 50 percent leased. AnaBios is joined by Novoron Bioscience, Excellos and Native Microbials in downtown’s newest wet lab building.
AnaBios will use the space to continue offering their clients cutting-edge drug discovery and research translational services based on of high-quality human tissue and cells, including heart, lung, and dorsal root ganglia.
“We believe that being located in downtown San Diego near other life science firms, the Convention Center and the airport will provide a key catalyst for our growth,” said Andre Ghetti, Founder and Chief Executive Officer at AnaBios. “The unmatched resources, inspiring environment, and unwavering commitment to innovation offered by Phase 3 Real Estate Partners align perfectly with our vision for the future.”
JLL’s Chad Urie, Grant Schoneman and Taylor DeBerry represented the landlord, Phase 3 Real Estate Partners, in the lease. AnaBios was represented by Jon Engle and John Hundley of Newmark. GENESIS San Diego can accommodate users ranging from 7,500 square feet and larger.
“Downtown San Diego is emerging as a vibrant hub for innovative life science companies, and AnaBios’ decision to join the impressive lineup at GENESIS reflects the area’s appeal,” said Jon Engle, Newmark Managing Director. “The city’s collaborative environment, coupled with the cutting-edge facilities provided by Phase 3 Real Estate Partners, is fostering an ecosystem where companies like AnaBios can thrive and advance groundbreaking discoveries and scientific research.”
Phase 3 Real Estate Partners Inc., in partnership with Barings and Bain Capital Real Estate, completed the Genesis-San Diego life science conversion in mid-2022, delivering robust infrastructure, premier finishes and thoughtful designs that were curated allowing today’s top biotech companies space to grow, and succeed in their endeavours. Learn more at www.GENESIS-SanDiego.com.
– ends –
About Phase 3 Real Estate Partners
Phase 3 Real Estate Partners, Inc., (“Phase 3”) develops premier ready to occupy research and development facilities in the major innovation clusters of the United States. Phase 3’s focus on delivering the highest quality space with accelerated speed to occupancy within these key geographies allows companies to immediately pursue their scientific goals. The Phase 3 team delivers a clean, modern design aesthetic, the right combination of amenities to create community and appropriate infrastructure to meet the needs of the companies who call our facilities home. The firm’s expertise in development, construction and management of life science facilities results in a strong partnership between our tenants and our team. Phase 3’s current portfolio consists of nearly 4.5 million square feet and is growing in San Diego, San Francisco and Boston. For more information, visit www.P3RE.com.
About Barings
Barings is a $362+ billion* global investment manager sourcing differentiated opportunities and building long-term portfolios across public and private fixed income, real estate, and specialist equity markets. With investment professionals based in North America, Europe and Asia Pacific, the firm, a subsidiary of MassMutual, aims to serve its clients, communities and employees, and is committed to sustainable practices and responsible investment.
*As of March 31, 2023
About Bain Capital Real Estate
Bain Capital Real Estate was formed in 2018 and pursues investments in often hard-to-access sectors underpinned by enduring secular trends that drive long-term demand growth for real estate assets and services. The Bain Capital Real Estate team has been executing its strategy since 2010 (formerly as a part of Harvard Management Company), having invested and committed more than $6.9 billion of equity in more than 550 assets across multiple sectors, including more than $1.7 billion in over 6.8 million SF of life sciences assets. Bain Capital Real Estate focuses on small to mid-sized assets where the team applies its deep industry expertise to accelerate impact and drive operational improvements. Bain Capital Real Estate’s strategy aligns with the value-added investment approach that Bain Capital pioneered and leverages the firm’s global platform and significant experience across asset classes to further bolster its insights and sourcing capabilities.
About JLL
For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500® company with annual revenue of $20.8 billion and operations in over 80 countries around the world, our more than 106,000 employees bring the power of a global platform combined with local expertise. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAYSM. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.
Contact: David Ebeling
Phone: 949 861 8351
Email: david@ebelingcomm.com
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
